Page last updated: 2024-10-19

phosphoenolpyruvate and Hematologic Diseases

phosphoenolpyruvate has been researched along with Hematologic Diseases in 1 studies

Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gherardi, M1
Bierme, R1
Corberand, J1
Vergnes, H1

Other Studies

1 other study available for phosphoenolpyruvate and Hematologic Diseases

ArticleYear
Heterogeneity of erythrocyte pyruvate kinase deficiency and related metabolic disorders in patients with hematological diseases.
    Clinica chimica acta; international journal of clinical chemistry, 1977, Aug-01, Volume: 78, Issue:3

    Topics: Adenine Nucleotides; Adenosine Triphosphate; Anemia, Hemolytic, Congenital Nonspherocytic; Diphospho

1977